We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Let’s check out how things have shaped up for the announcement.
Expectations This Time Around
The Zacks Consensus Estimate for IQVIA Holdings’ second-quarter 2022 revenues is pegged at $3.50 billion, indicating growth of 2% from the year-ago period’s reported figure, attributable to strength across segments, namely Research & Development Solutions (R&DS) and Technology & Analytics Solutions (TAS). The consensus estimate for revenues lies within the guided range of $3.47-$3.52 billion.
The consensus mark for R&DS revenues is pegged at $1.94 billion, suggesting growth of 2.6% from the year-ago quarter’s reported figure. The consensus estimate for TAS revenues stands at $1.41 billion, indicating an increase of 4.4% from the year-ago quarter’s reported figure.
The Zacks Consensus Estimate for earnings is pegged at $2.39 per share, indicating growth of 12.2% from the year-ago quarter’s reported figure. The consensus estimate lies within the guided range of $2.35-$2.42. Operating performance is likely to have aided the bottom line.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for IQVIA Holdings this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
IQVIA Holdings has an Earnings ESP of +0.78% and a Zacks Rank #4 (Sell).
Stocks to Consider
Here are a few stocks worth considering from the broader Zacks Business Services sector, as our model shows that these have the right combination of elements to beat on second-quarter 2022 earnings:
ADP has an expected earnings growth rate of 16% for the current year. Automatic Data has a trailing four-quarter earnings surprise of 6.2%, on average.
Booz Allen Hamilton Holding Corporation (BAH - Free Report) has an Earnings ESP of +4.41% and a Zacks Rank of 3.
Booz Allen has an expected earnings growth rate of 3.3% for the current year. BAH has a trailing four-quarter earnings surprise of 9.5%, on average.
Cross Country Healthcare (CCRN - Free Report) has an Earnings ESP of +0.59% and is Zacks #3 Ranked.
Cross Country Healthcare has an expected earnings growth rate of 56% for the current year. CCRN delivered a trailing four-quarter earnings surprise of 29.2%, on average.
Image: Shutterstock
What's in the Offing for IQVIA Holdings (IQV) in Q2 Earnings?
IQVIA Holdings Inc. (IQV - Free Report) is scheduled to report second-quarter 2022 results on Jul 21, before market open.
Let’s check out how things have shaped up for the announcement.
Expectations This Time Around
The Zacks Consensus Estimate for IQVIA Holdings’ second-quarter 2022 revenues is pegged at $3.50 billion, indicating growth of 2% from the year-ago period’s reported figure, attributable to strength across segments, namely Research & Development Solutions (R&DS) and Technology & Analytics Solutions (TAS). The consensus estimate for revenues lies within the guided range of $3.47-$3.52 billion.
The consensus mark for R&DS revenues is pegged at $1.94 billion, suggesting growth of 2.6% from the year-ago quarter’s reported figure. The consensus estimate for TAS revenues stands at $1.41 billion, indicating an increase of 4.4% from the year-ago quarter’s reported figure.
IQVIA Holdings Inc. Price and EPS Surprise
IQVIA Holdings Inc. price-eps-surprise | IQVIA Holdings Inc. Quote
The Zacks Consensus Estimate for earnings is pegged at $2.39 per share, indicating growth of 12.2% from the year-ago quarter’s reported figure. The consensus estimate lies within the guided range of $2.35-$2.42. Operating performance is likely to have aided the bottom line.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for IQVIA Holdings this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
IQVIA Holdings has an Earnings ESP of +0.78% and a Zacks Rank #4 (Sell).
Stocks to Consider
Here are a few stocks worth considering from the broader Zacks Business Services sector, as our model shows that these have the right combination of elements to beat on second-quarter 2022 earnings:
Automatic Data Processing, (ADP - Free Report) has an Earnings ESP of +2.86% and a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
ADP has an expected earnings growth rate of 16% for the current year. Automatic Data has a trailing four-quarter earnings surprise of 6.2%, on average.
Booz Allen Hamilton Holding Corporation (BAH - Free Report) has an Earnings ESP of +4.41% and a Zacks Rank of 3.
Booz Allen has an expected earnings growth rate of 3.3% for the current year. BAH has a trailing four-quarter earnings surprise of 9.5%, on average.
Cross Country Healthcare (CCRN - Free Report) has an Earnings ESP of +0.59% and is Zacks #3 Ranked.
Cross Country Healthcare has an expected earnings growth rate of 56% for the current year. CCRN delivered a trailing four-quarter earnings surprise of 29.2%, on average.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.